mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0003 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |